Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ZENITH HEALTH vs MYLAN (US) - Comparison Results

MYLAN (US)
   Change

Mylan is one of the world’s leading generics and specialty pharmaceutical company. Its products span to customers in about 140 countries across the world. The company maintains one of the industry’s broadest and highest quality product portfolios, wh... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 ZENITH HEALTH   MYLAN
EQUITY SHARE DATA
    ZENITH HEALTH
Mar-23
MYLAN
Dec-18
ZENITH HEALTH/
MYLAN
5-Yr Chart
Click to enlarge
High Rs83,967-   
Low Rs42,184-   
Sales per share (Unadj.) Rs2.41,825.4-  
Earnings per share (Unadj.) Rs049.6-  
Cash flow per share (Unadj.) Rs0.1391.3-  
Dividends per share (Unadj.) Rs00-  
Avg Dividend yield %00-  
Book value per share (Unadj.) Rs1.31,974.7-  
Shares outstanding (eoy) m53.74514.50-   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x2.31.7 138.5%   
Avg P/E ratio x394.062.0 635.0%  
P/CF ratio (eoy) x85.67.9 1,088.8%  
Price / Book Value ratio x4.21.6 272.0%  
Dividend payout %00-   
Avg Mkt Cap Rs m3061,582,214 0.0%   
No. of employees `000NA35.0 0.0%   
Total wages/salary Rs m130-   
Avg. sales/employee Rs Th026,833.1-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th0728.6-  
INCOME DATA
Net Sales Rs m131939,158 0.0%  
Other income Rs m40-   
Total revenues Rs m135939,158 0.0%   
Gross profit Rs m0243,019 0.0%  
Depreciation Rs m3175,847 0.0%   
Interest Rs m045,170 0.0%   
Profit before tax Rs m122,002 0.0%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m0-3,500 -0.0%   
Profit after tax Rs m125,502 0.0%  
Gross profit margin %0.225.9 0.9%  
Effective tax rate %34.2-15.9 -214.7%   
Net profit margin %0.62.7 21.8%  
BALANCE SHEET DATA
Current assets Rs m71524,425 0.0%   
Current liabilities Rs m20382,364 0.0%   
Net working cap to sales %39.015.1 257.9%  
Current ratio x3.51.4 258.2%  
Inventory Days Days1484 16.4%  
Debtors Days Days64393 688.8%  
Net fixed assets Rs m20182,181 0.0%   
Share capital Rs m54500 10.7%   
"Free" reserves Rs m190-   
Net worth Rs m721,015,998 0.0%   
Long term debt Rs m01,096,588 0.0%   
Total assets Rs m912,725,301 0.0%  
Interest coverage x17.91.5 1,200.8%   
Debt to equity ratio x01.1 0.0%  
Sales to assets ratio x1.40.3 417.1%   
Return on assets %0.92.6 35.9%  
Return on equity %1.12.5 42.9%  
Return on capital %1.73.2 54.5%  
Exports to sales %00-   
Imports to sales %00-   
Net fx Rs m630-   
CASH FLOW
From Operations Rs m-9195,157 -0.0%  
From Investments Rs mNA-100,875 0.0%  
From Financial Activity Rs mNA-90,916 -0.0%  
Net Cashflow Rs m-101,617 -0.6%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for MYLAN (US) is United States Dollars. All data has been converted at 83.34 Rs / USD

Compare ZENITH HEALTH With: ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  

Compare ZENITH HEALTH With: THEMIS MEDICARE  PLETHICO PHARMA  LASA SUPERGENERICS  SHELTER PHARMA  WYETH  



Today's Market

Sensex Today Ends 487 Points Higher | Metal Stocks Shine | SBI & Axis Bank Zoom 5% Sensex Today Ends 487 Points Higher | Metal Stocks Shine | SBI & Axis Bank Zoom 5%(Closing)

After opening the day on high, Indian share markets continued the momentum as the session progressed and ended the higher.